|
KMID : 0359720220400020176
|
|
Journal of the Korean Neurological Association
2022 Volume.40 No. 2 p.176 ~ p.180
|
|
|
Plasmapheresis for a Female with Cryptogenic New-Onset Refractory Status Epilepticus Not Benefiting from Monoclonal Antibody Therapy
|
|
Ha Hong-Min
Kim Young-Soo
Kim Do-Hyung
Yang Tae-Won
Chung Bo-Ra
Lee Chan-Hyun
Kim Eun-Ji
Kwon Oh-Young
|
|
|
Abstract
|
|
|
|
Monoclonal antibodies are pure antibodies that react to a specific epitope. Plasmapheresis is a treatment that separates and eliminates disease-causing substances before replacing the blood with plasma. Plasmapheresis has insufficient evidence for treating new-onset refractory status epilepticus (NORSE). Sequential plasmaphereses gradually improved a female cryptogenic NORSE patient who did not benefit from monoclonal antibody treatment.
|
|
|
KEYWORD
|
|
|
Status epilepticus, Monoclonal antibodies, Plasmapheresis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|